dr. leslie on phase 1b trial of tazemetostat plus lenalidomide/rituximab in follicular lymphoma
Published 4 years ago • 184 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
1:48
tazemetostat in combination with lenalidomide and rituximab for r/r follicular lymphoma
-
1:31
dr. leonard on lenalidomide with rituximab in follicular lymphoma
-
1:22
dr. leslie on frontline treatment options in follicular lymphoma
-
0:42
results establishing lenalidomide plus rituximab as superior treatment in non-hodgkin lymphoma
-
2:20
tazemetostat lenalidomide & rituximab vs. lenalidomide & rituximab in patients with r/r fl
-
3:47
previously untreated fl: obinutuzumab plus lenalidomide
-
3:26
phase ii study of acalabrutinib, lenalidomide & rituximab for high tumor burden follicular lymphoma
-
5:12
phase ii trial of acalabrutinib, lenalidomide and rituximab in patients with mcl
-
1:16
dr. leonard on the fda approval of tazemetostat in follicular lymphoma
-
1:31
dr. leslie discusses duvelisib in follicular lymphoma
-
1:10
the relevance study: lenalidomide plus rituximab vs. rituximab-chemotherapy in the treatment of fl
-
4:55
results of the phase ib/ii trial of obinutuzumab-atezolizumab-lenalidomide for r/r fl
-
3:55
accelerated approval of tazemetostat for follicular lymphoma
-
3:44
etctn p10500: a phase i/expansion study of tazemetostat plus belinostat for r/r nhl
-
1:24
dr. michael williams on lenalidomide plus rituximab in first line mcl
-
1:03
relevance: rituximab and lenalidomide in fl
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
1:22
dr. leslie on sequencing zanubrutinib in mcl
-
5:59
sustained remission with lenalidomide plus rituximab as initial treatment for mantle cell lymphoma